首页    期刊浏览 2024年09月07日 星期六
登录注册

文章基本信息

  • 标题:Immune response to SARS-CoV-2 in severe disease and long COVID-19
  • 本地全文:下载
  • 作者:Tomonari Sumi ; Kouji Harada
  • 期刊名称:iScience
  • 印刷版ISSN:2589-0042
  • 出版年度:2022
  • 卷号:25
  • 期号:8
  • 页码:1-19
  • DOI:10.1016/j.isci.2022.104723
  • 语种:English
  • 出版社:Elsevier
  • 摘要:SummaryCOVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause life-threatening disease and/or a wide range of persistent symptoms. The general determinant of disease severity is age mainly because the immune response declines in aging patients. Here, we developed a mathematical model of the immune response to SARS-CoV-2 and revealed that typical age-related risk factors such as only a several 10% decrease in innate immune cell activity and inhibition of type-I interferon signaling by autoantibodies drastically increased the viral load. It was reported that the numbers of certain dendritic cell subsets remained less than half those in healthy donors even seven months after infection. Hence, the inflammatory response was ongoing. Our model predicted the persistent DC reduction and showed that certain patients with severe and even mild symptoms could not effectively eliminate the virus and could potentially develop long COVID.Graphical abstractDisplay OmittedHighlights•Systemic SARS-CoV-2 infection owing to ACE2 expression on a wide range of cell types•Persistent viral infection can be ongoing within the host even if it is not severe•Long-term dendritic cell deficiency is owing to viruses that cannot be removed by the host•Ongoing persistent viral infection within the host potentially causes long COVID or PASCImmunology; Virology; Mathematical biosciences
国家哲学社会科学文献中心版权所有